A preclinical study reveals that HER2 expression in mammosphere-forming BC with high levels of the stem cell markers Oct4 and Bmi1 is 2 to 7-fold higher than other group of the cells from the same origin. The gene discussed is POU5F1; the disease is breast cancer.